Enveric Biosciences (ENVB) EPS (Diluted) (2014 - 2026)
Enveric Biosciences (ENVB) EPS (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.15 |
| 10 | Enveric Biosciences | 5.50 Mn | -2.79 Mn | - | -0.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 |
| Dec 31, 2025 | -12.07 |
| Sep 30, 2025 | -10.81 |
| Jun 30, 2025 | -11.65 |
| Mar 31, 2025 | -14.59 |
| Dec 31, 2024 | -75.28 |
| Sep 30, 2024 | -43.10 |
| Jun 30, 2024 | -44.58 |
| Mar 31, 2024 | -110.52 |
| Dec 31, 2023 | -286.45 |
| Sep 30, 2023 | -234.68 |
| Jun 30, 2023 | -546.57 |
| Mar 31, 2023 | -415.80 |
| Dec 31, 2022 | -1,095.67 |
| Sep 30, 2022 | -262.11 |
| Jun 30, 2022 | -490.66 |
| Mar 31, 2022 | -30,775.61 |
| Dec 31, 2021 | -286,431.90 |
| Sep 30, 2021 | -18,451.74 |
| Jun 30, 2021 | -6,178.84 |